XOMA Co. (NASDAQ:XOMAP – Get Free Report) was the target of a large growth in short interest in the month of April. As of April 15th, there was short interest totaling 1,568 shares, a growth of 150.9% from the March 31st total of 625 shares. Based on an average trading volume of 933 shares, the days-to-cover ratio is currently 1.7 days.
XOMA Price Performance
Shares of XOMA stock opened at $26.13 on Monday. The firm’s fifty day simple moving average is $26.09 and its 200-day simple moving average is $26.36. XOMA has a 12 month low of $25.21 and a 12 month high of $30.00.
XOMA Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 15th. Shareholders of record on Thursday, April 2nd were paid a $0.5391 dividend. This represents a $2.16 annualized dividend and a yield of 8.3%. The ex-dividend date of this dividend was Thursday, April 2nd.
About XOMA
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Featured Articles
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
